Cargando…
Immunohistochemical assessment of cannabinoid type-1 receptor (CB1R) and its correlation with clinicopathological parameters in glioma
BACKGROUND: Glioma is the most frequent primary brain tumor and one of the most aggressive forms of cancer. Recently, numerous studies have focused on cannabinoids as a new therapeutic approach due to their antineoplastic effects through activation of the cannabinoid receptors. This study aimed to i...
Autores principales: | Choucair, Nader, Saker, Zahraa, Eddine, Hassane Kheir, Bahmad, Hisham F., Fares, Youssef, Zaarour, Mariana, Harati, Hayat, Nabha, Sanaa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pacini Editore srl
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248256/ https://www.ncbi.nlm.nih.gov/pubmed/35481563 http://dx.doi.org/10.32074/1591-951X-294 |
Ejemplares similares
-
Prognostic impact of adenylyl cyclase-associated protein 2 (CAP2) in glioma: A clinicopathological study
por: Saker, Zahraa, et al.
Publicado: (2020) -
Post-traumatic stress disorder in adult victims of cluster munitions in Lebanon: a 10-year longitudinal study
por: Fares, Jawad, et al.
Publicado: (2017) -
Cannabinoid CB(1) and CB(2) Receptor Signaling and Bias
por: Ibsen, Mikkel Søes, et al.
Publicado: (2017) -
Cannabigerol Action at Cannabinoid CB(1) and CB(2) Receptors and at CB(1)–CB(2) Heteroreceptor Complexes
por: Navarro, Gemma, et al.
Publicado: (2018) -
Cannabinoid CB1 receptors regulate salivation
por: Andreis, Kelsey, et al.
Publicado: (2022)